Long‐term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14219 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Míriam Mañosa und 9 weiteren Autor:innen. Beteiligte Einrichtung: IBD Unit, Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain. Hauptthemen laut MEDLINE: Crohn Disease, Recurrence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Early endoscopic evaluation is recommended for assessment of postoperative recurrence (POR) of Crohn's disease (CD) but no further monitoring recommendations are available.
Aim
To evaluate the long‐term outcome of patients without endoscopic POR at first endoscopic assessment.
Methods
Retrospective four‐centre study including consecutive CD patients with ileocolonic resection (ICR) without endoscopic POR (Rutgeerts score i0‐i1) at first endoscopic assessment performed within 18 months from ICR. All patients had a clinical follow‐up ≥24 months and at least one further endoscopic assessment. Main outcomes were endoscopic, clinical and surgical POR, need for rescue therapy and “delayed POR” (any need for rescue therapy or clinical or surgical POR) during follow‐up.
Results
Overall, 183 patients were included (79% with risk factors for POR, 44% without postoperative prophylaxis). Endoscopic POR was observed in 42% of patients. Clinical POR‐free survival was 89.4% and 81.5% at 3 and 5 years, and delayed POR‐free survival was 76.9% and 63.4% at 5 and 10 years, respectively. In multivariate analysis, postoperative prophylaxis (HR .55; 95% CI .325–.942) and active smoking (HR 1.72; 95%CI 1.003–2.962) were independent risk factors for clinical POR, whereas presence of mild endoscopic lesions at index ileocolonoscopy (i1) was the only risk factor for delayed POR (HR 1.824; 95% CI 1.108–3.002).
Conclusions
Long‐term risk of POR among patients with no or mild endoscopic lesions at first ileocolonoscopy after surgery is steadily low, being higher among smokers, in the absence of postoperative prophylaxis and when mild endoscopic lesions are observed in the first endoscopic assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IBD Unit, Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
- Service d'Hépato-Gastroentérologie et Oncologie Digestive, CHU de Bordeaux, Bordeaux, France.
- INSERM CIC 1401, Bordeaux, France.
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
- Translational Research in Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
ORCID-Profile: Míriam Mañosa, Margalida Calafat, Eugeni Domènech
Zitieren
APA
Mañosa, M., Rivière, P., de Greef, I., Oller, B., Roig, C., Calafat, M., Garcia-Planella, E., Laharie, D., Ferrante, M., & Domènech, E. (2024). Long‐term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14219
Vancouver
Mañosa M, Rivière P, de Greef I, Oller B, Roig C, Calafat M, et al. Long‐term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14219
BibTeX
@article{Maosa2024,
author = {Mañosa, Míriam and Rivière, Pauline and de Greef, Ine and Oller, Blanca and Roig, Cristina and Calafat, Margalida and Garcia-Planella, Esther and Laharie, David and Ferrante, Marc and Domènech, Eugeni},
title = {Long‐term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14219}
}
EUVIMED